Sarcoidosis vasculitis and diffuse lung diseases

Published: 2011-12-01


How to build a biomarker: IL-7 and acute exacerbation of IPF

C.J. Ryerson, H.R. Colard
Abstract 74 | PDF (Italiano) Downloads 35

Page 83-84


Original Articles: Laboratory Research

IPrognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects

S.H. Lee, H.S. Shim, S.H. Cho, et al.
Abstract 115 | PDF (Italiano) Downloads 42

Page 102-112

Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker

K. Tachibana, Y. Inoue, A. Nishiyama, et al.
Abstract 432 | PDF (Italiano) Downloads 65

Page 113-122

Original Articles: Clinical Research

18F-FDG PET as a predictor of pulmonary function in sarcoidosis

R.G. Keijsers, F.J. Verzijlbergen, J.M. van den Bosch, et al.
Abstract 149 | PDF (Italiano) Downloads 76

Page 123-129

Optimal scoring of serial change on chest radiography in sarcoidosis

C.J. Zappala, S.R. Desai, S.J. Copley, et al.
Abstract 143 | PDF (Italiano) Downloads 49

Page 130-138

Ambrisentan for sarcoidosis associated pulmonary hypertension

M.A. Judson, KB. Highland, S. Kwon, et al.
Abstract 161 | PDF (Italiano) Downloads 80

Page 139-145

Case Reports

Sarcoidosis and lymphoma: case series and literature review:

H. Maayan, Y. Ashkenazi, A. Nagler, et al.
Abstract 136 | PDF (Italiano) Downloads 75

Page 146-152

Successful pregnancy complicated by persistent pneumothorax in a patient with lymphangioleiomyomatosis (LAM) on sirolimus

>M. Faehling, S. Frohnmayer, M. Leschke, et al.
Abstract 213 | PDF (Italiano) Downloads 125

Page 153-155

Conference Report